Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L O’Leary, B. Tildy, I. Papazoglou, I.M. Adcock, K.F. Chung, M. Perry (London, United Kingdom). miRNA-145 & SMAD3 expression in patients with COPD. Eur Respir J 2014; 44: Suppl. 58, 3342

Member's Comments

No comment yet.

Related content which might interest you: The effect of JQ1/SGCBD01 upon c-Myc in human airway smooth muscle in asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 The anti-proliferative effect of hydrogen sulfide upon human airway smooth muscle in COPD Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Mitochondrial membrane potential in the airway and skeletal muscle compartments of smokers with and without COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 HMGB1 is upregulated in ASM in asthma and induces ASM contraction via TLR4 Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration Source: International Congress 2014 – Cell biology 2014 Year: 2014 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Klotho expression is reduced in COPD Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 A functional role for WNT-5A in driving airway myocyte proliferation Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Reduced MicroRNA-19a causes constitutive high expression of PRMT1 and remodeling in asthma Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Role of protein phosphatase 5 (PP5) in mediating corticosteroid insensitivity in airway smooth muscle (ASM) cells in severe asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Corticosteroid insensitivity in airway smooth muscle cells from severe asthma is dependent on stimulus and cytokine product Source: International Congress 2014 – Cell biology 2014 Year: 2014 Pharmacologic bronchodilation response to salbutamol in COPD patients Source: International Congress 2014 – Predictors Year: 2014 COPD airway epithelium secretion attracts and activates neutrophils Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Mitochondrial reactive oxygen species (ROS) mediate proliferation and cytokine release in airway smooth muscle cells of patients with COPD Source: International Congress 2014 – Cell biology 2014 Year: 2014 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 Association between cardio-ankle vascular index (CAVI) and chronic airway obstruction in asthma Source: International Congress 2016 – Monitoring comorbidities Year: 2016